Litcius/Paper detail

Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α

Alexis Mathian, Paul Breillat, Karim Dorgham, Paul Bastard, Caroline Charre, Raphaël Lhote, Paul Quentric, Quentin Moyon, Alice‐Andrée Mariaggi, S. Mouriès-Martin, Clara Mellot, François Anna, Julien Haroche, Fleur Cohen‐Aubart, Delphine Sterlin, Noël Zahr, Adrian Gervais, Tom Le Voyer, Lucy Bizien, Quentin Amiot, M. Pha, Miguel Hié, François Chasset, Hans Yssel, Makoto Miyara, Pierre Charneau, Pascale Ghillani‐Dalbin, Jean‐Laurent Casanova, Flore Rozenberg, Zahir Amoura, Guy Gorochov

2022Annals of the Rheumatic Diseases80 citationsDOIOpen Access PDF

Topics & Concepts

MedicineImmunologyAutoantibodyAntibodyImmunogenicitySystemic lupus erythematosusPneumoniaAutoimmunityVirologyDiseaseInternal medicineSystemic Lupus Erythematosus ResearchSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies
Lower disease activity but higher risk of severe COVID-19 and herpes zoster in patients with systemic lupus erythematosus with pre-existing autoantibodies neutralising IFN-α | Litcius